Discovery of 1,4-dihydroxy-2-naphthoate [corrected] prenyltransferase inhibitors: new drug leads for multidrug-resistant gram-positive pathogens.
Michio Kurosu, Prabagaran Narayanasamy, Kallolmay Biswas, Rakesh Dhiman, Dean C Crick
文献索引:J. Med. Chem. 50 , 3973-5, (2007)
全文:HTML全文
摘要
Since utilization of menaquinone in the electron transport system is a characteristic of Gram-positive organisms, the 1,4-dihydroxy-2-naphthoate prenyltransferase (MenA) inhibitors 1a and 2a act as selective antibacterial agents against organisms such as methicillin-resistant Stapylococcus aureus (MRSA), Staphylococcus epidermidis (MRSE), and Mycobacterium spp. Growth of drug-resistant Gram-positive organisms was sensitive to the MenA inhibitors, indicating that menaquinone synthesis is a valid new drug target in Gram-positive organisms.
相关化合物
相关文献:
2014-12-01
[Tuberculosis (Edinb.) 94(6) , 701-7, (2015)]
2015-02-01
[PLoS Pathog. 11(2) , e1004645, (2015)]
2014-12-01
[J. Antimicrob. Chemother. 69(12) , 3199-202, (2014)]
2014-01-01
[PLoS ONE 9(4) , e93953, (2014)]
2015-02-01
[Pulm. Pharmacol. Ther. 30 , 80-6, (2015)]